Symbyax (Eli Lilly and Company)


Welcome to the PulseAid listing for the Symbyax drug offered from Eli Lilly and Company. This Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Eli Lilly and Company
NON-PROPRIETARY NAME: Olanzapine and Fluoxetine hydrochloride
SUBSTANCE NAME: OLANZAPINE; FLUOXETINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2007-04-09
END MARKETING DATE: 0000-00-00


Symbyax HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSymbyax from Eli Lilly and Company
LABELER NAME: Eli Lilly and Company
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 25(mg/1; mg/1)
START MARKETING DATE: 2007-04-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0002-3230_7de92fb4-d903-4b94-a776-f9b083fd363c
PRODUCT NDC: 0002-3230
APPLICATION NUMBER: NDA021520

Other OLANZAPINE; FLUOXETINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AvKARE, Inc.Olanzapine and Fluoxetine
Eli Lilly and CompanySymbyax
Par Pharmaceutical, IncOlanzapine and Fluoxetine
Sandoz IncOlanzapine and Fluoxetine
Teva Pharmaceuticals USA, Inc.Olanzapine and Fluoxetine